603658 安图生物
已收盘 12-20 15:00:00
资讯
新帖
简况
安图生物12月20日主力资金净流出1140.17万元
金融界 · 12-20 17:55
安图生物12月20日主力资金净流出1140.17万元
安图生物:关于独立董事辞职的公告
新浪财经-鹰眼工作室 · 12-20 17:01
安图生物:关于独立董事辞职的公告
安图生物最新公告:独立董事顾军辞职
证券之星 · 12-20 16:56
安图生物最新公告:独立董事顾军辞职
安图生物(603658)12月18日主力资金净买入241.26万元
证券之星 · 12-19 08:20
安图生物(603658)12月18日主力资金净买入241.26万元
安图生物12月13日主力资金流入1457万元 连续3日加仓
市场透视 · 12-13
安图生物12月13日主力资金流入1457万元 连续3日加仓
安图生物与Mobidiag达成和解 获赔1000万美元和解款
财中社 · 12-12
安图生物与Mobidiag达成和解 获赔1000万美元和解款
安图生物(603658.SH)实控人完成增持45.28万股
智通财经 · 12-12
安图生物(603658.SH)实控人完成增持45.28万股
安图生物:AI引领 开启智慧化检验新纪元
中国财富通 · 12-12
安图生物:AI引领 开启智慧化检验新纪元
安图生物:拟使用闲置募集资金进行现金管理
格隆汇资讯 · 12-11
安图生物:拟使用闲置募集资金进行现金管理
刚刚!安图生物,被出具警示函!
谈思生物 · 12-10
刚刚!安图生物,被出具警示函!
审议关联议案部分董事未回避表决,安图生物被出具警示函 公司:将以此为戒,切实提升内控水平
每日经济新闻 · 12-10
审议关联议案部分董事未回避表决,安图生物被出具警示函 公司:将以此为戒,切实提升内控水平
安图生物因涉嫌违反证券法律法规等违规行为被证监会出具警示函
证券之星 · 12-10
安图生物因涉嫌违反证券法律法规等违规行为被证监会出具警示函
安图生物最新公告:收到中国证券监督管理委员会河南监管局行政监管措施决定书
证券之星 · 12-09
安图生物最新公告:收到中国证券监督管理委员会河南监管局行政监管措施决定书
安图生物(603658.SH)及有关责任人员收河南证监局警示函
智通财经 · 12-09
安图生物(603658.SH)及有关责任人员收河南证监局警示函
安图生物12月06日获主力加仓1583万元 环比增加1117.69%
市场透视 · 12-06
安图生物12月06日获主力加仓1583万元 环比增加1117.69%
安图生物(603658.SH)已耗资4.34亿元回购1.60%股份
智通财经 · 12-02
安图生物(603658.SH)已耗资4.34亿元回购1.60%股份
安图生物11月28日主力资金流出505万元 连续5日减仓
市场透视 · 11-28
安图生物11月28日主力资金流出505万元 连续5日减仓
1-10月医保统筹收入稳增长,机构:医药后市反转源于三大机会
汇添富基金 · 11-28
1-10月医保统筹收入稳增长,机构:医药后市反转源于三大机会
安图生物11月26日遭主力抛售218万元 环比增加938.10%
市场透视 · 11-26
安图生物11月26日遭主力抛售218万元 环比增加938.10%
医药早参|安图生物5项产品获得医疗器械注册证
每日经济新闻 · 11-26
医药早参|安图生物5项产品获得医疗器械注册证
暂无数据
公司概况
公司名称:
郑州安图生物工程股份有限公司
所属行业:
医药制造业
上市日期:
2016-09-01
主营业务:
郑州安图生物工程股份有限公司专业从事体外诊断试剂及仪器的研发、制造、整合及服务,产品涵盖免疫、微生物、生化等检测领域,同时也在分子检测等领域积极布局,能够为医学实验室提供全面的产品解决方案和整体服务。公司产品按照检测方法或应用领域分类,主要分为以下几类:免疫类诊断试剂、微生物检测试剂、生化检测试剂、分子检测试剂、免疫类、微生物类、分子类、临床检验及其他辅助设备。公司产品覆盖了从传染病到非传染病的诸多方向,是我国业内提供免疫检测产品较多的企业之一,也是国内能够提供全面免疫检测解决方案的企业之一。
发行价格:
14.58
{"stockData":{"symbol":"603658","market":"SH","secType":"STK","nameCN":"安图生物","latestPrice":44.99,"timestamp":1734678000000,"preClose":44.57,"halted":0,"volume":3722266,"delay":0,"floatShares":581000000,"shares":581000000,"eps":2.1905,"marketStatus":"已收盘","marketStatusCode":5,"change":0.42,"latestTime":"12-20 15:00:00","open":44.57,"high":45.74,"low":44.53,"amount":169000000,"amplitude":0.0271,"askPrice":45,"askSize":17,"bidPrice":44.99,"bidSize":51,"shortable":0,"etf":0,"ttmEps":2.1905,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734917400000},"adr":0,"adjPreClose":44.57,"symbolType":"stock","openAndCloseTimeList":[[1734658200000,1734665400000],[1734670800000,1734678000000]],"highLimit":49.03,"lowLimit":40.11,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":581011346,"pbRate":3.11,"roa":"--","roe":"11.06%","epsLYR":2.1,"committee":-0.316364,"marketValue":26140000000,"floatMarketCap":26140000000,"peRate":20.53869,"changeRate":0.0094,"turnoverRate":0.0064,"status":0,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2024-12-23。"},"requestUrl":"/m/hq/s/603658/tweets","defaultTab":"tweets","newsList":[{"id":"2492415172","title":"安图生物12月20日主力资金净流出1140.17万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492415172","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492415172?lang=zh_cn&edition=full","pubTime":"2024-12-20 17:55","pubTimestamp":1734688549,"startTime":"0","endTime":"0","summary":"资金流向方面,今日主力资金净流出1140.17万元,占比成交额6.76%。安图生物最新一期业绩显示,截至2024三季报,公司营业总收入33.80亿元、同比增长4.24%,归属净利润9.56亿元,同比增长6.13%,扣非净利润9.30亿元,同比增长6.69%,流动比率2.569、速动比率2.179、资产负债率25.49%。通过天眼查大数据分析,郑州安图生物工程股份有限公司共对外投资了19家企业,参与招投标项目861次,知识产权方面有商标信息80条,专利信息555条,此外企业还拥有行政许可1360个。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220181440a1fd741a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220181440a1fd741a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","BK0046","603658"],"gpt_icon":0},{"id":"2492491259","title":"安图生物:关于独立董事辞职的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2492491259","media":"新浪财经-鹰眼工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492491259?lang=zh_cn&edition=full","pubTime":"2024-12-20 17:01","pubTimestamp":1734685260,"startTime":"0","endTime":"0","summary":"郑州安图生物工程股份有限公司关于独立董事辞职的公告本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。公司将按照相关规定,尽快完成独立董事及各专门委员会的补选工作。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2024-12-20/doc-ineacaap3019521.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","BK0046","603658"],"gpt_icon":0},{"id":"2492491323","title":"安图生物最新公告:独立董事顾军辞职","url":"https://stock-news.laohu8.com/highlight/detail?id=2492491323","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492491323?lang=zh_cn&edition=full","pubTime":"2024-12-20 16:56","pubTimestamp":1734685008,"startTime":"0","endTime":"0","summary":"安图生物公告称,公司董事会近日收到独立董事顾军的书面辞职报告,顾军因个人原因申请辞去公司第五届董事会独立董事职务,同时一并辞去公司董事会专门委员会相关职务,辞职后将不再担任公司任何职务。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024122000027579.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0239","603658"],"gpt_icon":0},{"id":"2492016437","title":"安图生物(603658)12月18日主力资金净买入241.26万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492016437","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492016437?lang=zh_cn&edition=full","pubTime":"2024-12-19 08:20","pubTimestamp":1734567615,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年12月18日收盘,安图生物报收于46.12元,上涨2.47%,换手率0.61%,成交量3.55万手,成交额1.63亿元。近5日资金流向一览见下表:安图生物融资融券信息显示,融资方面,当日融资买入1312.26万元,融资偿还1072.5万元,融资净买入239.76万元,连续3日净买入累计4568.64万元。安图生物主营业务:专注于体外诊断试剂和仪器的研发、制造、整合及服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121900007661.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","603658"],"gpt_icon":0},{"id":"2491309707","title":"安图生物12月13日主力资金流入1457万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2491309707","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491309707?lang=zh_cn&edition=full","pubTime":"2024-12-13 15:20","pubTimestamp":1734074447,"startTime":"0","endTime":"0","summary":"12月13日, 安图生物股价跌0.75%,报收45.18元,成交金额1.66亿元,换手率0.63%,振幅2.15%,量比1.13。安图生物今日主力资金净流入1457万元,连续3日净流入,上一交易日主力净流入3548万元,今日环比减少58.93%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为23.53%,平均涨幅为1.27%。该股近5个交易日下跌1.01%,主力资金累计净流入5123万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流入7624万元,其中净流入天数为11日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213154358ab74abf2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213154358ab74abf2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0046","BK0239","603658"],"gpt_icon":0},{"id":"2491733181","title":"安图生物与Mobidiag达成和解 获赔1000万美元和解款","url":"https://stock-news.laohu8.com/highlight/detail?id=2491733181","media":"财中社","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491733181?lang=zh_cn&edition=full","pubTime":"2024-12-12 17:24","pubTimestamp":1733995440,"startTime":"0","endTime":"0","summary":"公司及子公司安图莫比和安图仪器与被申请人Mobidiag就合资协议和许可、开发与分销协议履行产生分歧,向国际商会国际仲裁院提交仲裁申请。近期,双方达成和解并签署协议,Mobidiag将向公司支付和解款1000万美元。仲裁费用共计14万美元,双方各承担50%,公司需承担7万美元。2024年前三季度,安图生物实现收入33.80亿元,归母净利润9.56亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212172719a1e8af4c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212172719a1e8af4c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603658","BK0046","BK0239"],"gpt_icon":0},{"id":"2490872941","title":"安图生物(603658.SH)实控人完成增持45.28万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2490872941","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490872941?lang=zh_cn&edition=full","pubTime":"2024-12-12 17:11","pubTimestamp":1733994675,"startTime":"0","endTime":"0","summary":"智通财经APP讯,安图生物(603658.SH)发布公告,截至2024年12月12日,董事长、实际控制人苗拥军本次增持计划实施期限已届满,苗拥军通过上海证券交易所交易系统集中竞价交易方式累计增持公司股份45.28万股,占公司总股本的0.0779%,累计增持金额为21,021,355元,本次增持计划已实施完毕。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1224026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0046","603658","BK0239"],"gpt_icon":0},{"id":"2490484832","title":"安图生物:AI引领 开启智慧化检验新纪元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490484832","media":"中国财富通","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490484832?lang=zh_cn&edition=full","pubTime":"2024-12-12 08:30","pubTimestamp":1733963454,"startTime":"0","endTime":"0","summary":"业内人士指出,在体外诊断领域,借助人工智能的学习能力和超算能力,使检验人员能够从繁琐和重复性的工作中解放出来,如智能采血机器人、智能阅片、智能审核、智能报告解读等应用不仅大幅提升了工作效率,更为临床决策提供了精准有力的支持,在AI技术的加持下,医学实验室开启了智慧化检验的新纪元。人工智能赋能血清质量识别值得一提的,安图生物全新自主研发生产的自动化流水线Autolas X-1 Series,将AI技术引入到自动化流水线。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://irb.cfbond.com/api/v1/detail.html?newsid=ZI3qdYDBcsg%3D","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK0046","603658"],"gpt_icon":0},{"id":"2490861246","title":"安图生物:拟使用闲置募集资金进行现金管理","url":"https://stock-news.laohu8.com/highlight/detail?id=2490861246","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490861246?lang=zh_cn&edition=full","pubTime":"2024-12-11 16:56","pubTimestamp":1733907374,"startTime":"0","endTime":"0","summary":"格隆汇12月11日丨安图生物(603658.SH)公布,为提高闲置募集资金的收益,在确保不影响募集资金投资项目建设和募集资金使用的情况下,公司拟分别使用不超过1.7亿元公开发行可转换公司债券闲置募集资金和不超过17亿元非公开发行股票闲置募集资金进行现金管理,分别用于购买单次持有期限不超过12个月的结构性存款、大额存单、国债逆回购、券商收益凭证、券商理财产品等安全性高、流动性好的保本型产品。在上述额度范围内,资金可在12个月内滚动使用。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211165630a1e5b502&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211165630a1e5b502&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","BK0046","603658"],"gpt_icon":0},{"id":"2490408024","title":"刚刚!安图生物,被出具警示函!","url":"https://stock-news.laohu8.com/highlight/detail?id=2490408024","media":"谈思生物","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490408024?lang=zh_cn&edition=full","pubTime":"2024-12-10 19:12","pubTimestamp":1733829129,"startTime":"0","endTime":"0","summary":"12月9日晚,安图生物发布公告称,公司于近日收到河南证监局出具的行政监管措施决定书《关于对郑州安图生物工程股份有限公司及有关责任人员采取出具警示函措施的决定》。经查,河南证监局发现安图生物存在部分董事在董事会审议关联议案中未回避表决、内幕信息知情人登记管理不规范的问题。安图生物获批国家企业技术中心、新发突发重大传染病检测国家工程研究中心、免疫检测自动化国家地方联合工程实验室等创新平台。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210193802a1e34270&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210193802a1e34270&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603658","BK0239","BK0046"],"gpt_icon":0},{"id":"2490024470","title":"审议关联议案部分董事未回避表决,安图生物被出具警示函 公司:将以此为戒,切实提升内控水平","url":"https://stock-news.laohu8.com/highlight/detail?id=2490024470","media":"每日经济新闻","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490024470?lang=zh_cn&edition=full","pubTime":"2024-12-10 19:00","pubTimestamp":1733828455,"startTime":"0","endTime":"0","summary":"经查,公司存在部分董事在董事会审议关联议案中未回避表决、内幕信息知情人登记管理不规范的问题,不符合相关规定。安图生物也在公告中表示,公司将以此为戒,后续加强对证券法律法规的学习,进一步强化规范运作意识,切实提升公司内部控制和规范运作水平。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210190918ab6c9136&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210190918ab6c9136&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","BK0046","603658"],"gpt_icon":0},{"id":"2490708170","title":"安图生物因涉嫌违反证券法律法规等违规行为被证监会出具警示函","url":"https://stock-news.laohu8.com/highlight/detail?id=2490708170","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490708170?lang=zh_cn&edition=full","pubTime":"2024-12-10 01:00","pubTimestamp":1733763640,"startTime":"0","endTime":"0","summary":"证券之星消息,12月10日安图生物公开信息显示,郑州安图生物工程股份有限公司,董事长苗拥军、副总经理房瑞宽因涉嫌违反证券法律法规,未依法履行其他职责被中国证券监督管理委员会河南监管局出具警示函。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121000000442.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0239","603658","161027"],"gpt_icon":0},{"id":"2490745504","title":"安图生物最新公告:收到中国证券监督管理委员会河南监管局行政监管措施决定书","url":"https://stock-news.laohu8.com/highlight/detail?id=2490745504","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490745504?lang=zh_cn&edition=full","pubTime":"2024-12-09 16:46","pubTimestamp":1733734010,"startTime":"0","endTime":"0","summary":"安图生物公告称,公司近日收到河南证监局出具的行政监管措施决定书。经查,公司存在部分董事在董事会审议关联议案中未回避表决、内幕信息知情人登记管理不规范的问题,不符合相关规定。苗拥军作为公司董事长、房瑞宽作为公司董事会秘书,对上述事项负有主要责任。河南证监局决定对公司、苗拥军、房瑞宽采取出具警示函的行政监管措施,并记入证券期货市场诚信档案。公司及上述人员高度重视,并严格按照监管要求积极落实整改工作。本次行政监管措施不会影响公司正常的经营管理活动。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120900021183.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603658","BK0239","BK0046"],"gpt_icon":0},{"id":"2490748041","title":"安图生物(603658.SH)及有关责任人员收河南证监局警示函","url":"https://stock-news.laohu8.com/highlight/detail?id=2490748041","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490748041?lang=zh_cn&edition=full","pubTime":"2024-12-09 16:40","pubTimestamp":1733733626,"startTime":"0","endTime":"0","summary":"智通财经APP讯,安图生物 发布公告,公司于近日收到中国证券监督管理委员会河南监管局出具的行政监管措施决定书〔2024〕100号《关于对郑州安图生物工程股份有限公司及有关责任人员采取出具警示函措施的决定》。苗拥军作为公司董事长、房瑞宽作为公司董事会秘书,对上述事项负有主要责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1222133.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"安图生物(603658.SH)及有关责任人员收河南证监局警示函","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0046","BK0239","603658"],"gpt_icon":0},{"id":"2489286100","title":"安图生物12月06日获主力加仓1583万元 环比增加1117.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489286100","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489286100?lang=zh_cn&edition=full","pubTime":"2024-12-06 15:18","pubTimestamp":1733469530,"startTime":"0","endTime":"0","summary":"12月06日, 安图生物股价涨1.00%,报收45.64元,成交金额1.37亿元,换手率0.52%,振幅2.08%,量比1.39。安图生物今日主力资金净流入1583万元,连续3日净流入,上一交易日主力净流入130万元,今日环比增加1117.69%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为23.53%,平均涨幅为1.27%。该股近5个交易日下跌1.79%,主力资金累计净流入2548万元;近20日主力资金累计净流出1893万元,其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206152606a1d88357&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206152606a1d88357&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0046","603658","BK0239"],"gpt_icon":0},{"id":"2488629259","title":"安图生物(603658.SH)已耗资4.34亿元回购1.60%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2488629259","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488629259?lang=zh_cn&edition=full","pubTime":"2024-12-02 17:35","pubTimestamp":1733132101,"startTime":"0","endTime":"0","summary":"智通财经APP讯,安图生物(603658.SH)发布公告,截至2024年11月30日,公司通过集中竞价交易方式已累计回购股份930.88万股,占公司总股本的比例为1.60%,成交的最高价为59.99元/股、最低价为37.91元/股,已支付的总金额为4.34亿元(不含交易费用)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1219051.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0046","603658","BK0239"],"gpt_icon":0},{"id":"2486369558","title":"安图生物11月28日主力资金流出505万元 连续5日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2486369558","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486369558?lang=zh_cn&edition=full","pubTime":"2024-11-28 15:20","pubTimestamp":1732778435,"startTime":"0","endTime":"0","summary":"11月28日, 安图生物股价跌1.12%,报收45.93元,成交金额1.22亿元,换手率0.45%,振幅2.71%,量比0.92。安图生物今日主力资金净流出505万元,连续5日净流出,上一交易日主力净流出321万元,今日环比增加57.32%。近一年数据显示,该股主力连续5日净流出后,次日下跌概率为16.67%,平均跌幅为0.13%。该股近5个交易日下跌1.20%,主力资金累计净流出1089万元,其中3个交易日为股价上涨时净流出;近20日主力资金累计净流出5568万元,其中净流出天数为16日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128153749a25bc4fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128153749a25bc4fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603658","BK0239","BK0046"],"gpt_icon":0},{"id":"2486387128","title":"1-10月医保统筹收入稳增长,机构:医药后市反转源于三大机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2486387128","media":"汇添富基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486387128?lang=zh_cn&edition=full","pubTime":"2024-11-28 08:11","pubTimestamp":1732752682,"startTime":"0","endTime":"0","summary":"消息面上,据医保局日前披露,2024年1-10月医保统筹基金收入23065.07亿元,同比增长8.9%;2024年1-10月统筹支出19165.88亿元,同比增长8.9%。对此,国泰君安表示,1-10月医保统筹基金运行平稳,收入稳健增长,支出增速逐月收窄。国金证券表示,由于多方面因素,医药板块景气度在2021年后经历了长时间的下行。2024年11月7日,国家医保局召开了座谈会,强调了全国统一医保平台和大数据赋能商保发展的重要性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112807590598e4504f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112807590598e4504f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688139","688356","688575","688266","688670","600535","688617","603301","BK0185","600252","688105","600771","605199","600422","688247","603259","688506","600511","603658","688176","600721","600161","688276","600572","600200","603439","603707","688029","603309","688137","688046","600436","688488","603127","688091","688298","600055","688198","603882","688050","603538","688271","603896","600998","688212","600488","600739","600529","BK0028","688520","BK0188","688177","600211","688336","600085","688581","600129","688062","BK0070","600062","688626","688443","BK0012","605177","600867","688235","600079","603939","688180","688192","688166","688301","600080","688278","600763","688193","688656","688161","603233","600566","603567","600521","603392","688321","688687","688117","603456","688202","688315","600196","603590","688382","688067","159938","688085","688373","603108","688767","600285","600380","601607","688114","688351","688578","688389","BK0096","688566","688189","600976","688428","600056","688690","BK0239","600276","688222","603367","688076","600329","600420","600332","600851","688331","603087","688073","600351","688658","603858","688163","688221"],"gpt_icon":0},{"id":"2486704446","title":"安图生物11月26日遭主力抛售218万元 环比增加938.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486704446","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486704446?lang=zh_cn&edition=full","pubTime":"2024-11-26 15:20","pubTimestamp":1732605639,"startTime":"0","endTime":"0","summary":"11月26日, 安图生物股价涨1.25%,报收45.20元,成交金额9124万元,换手率0.35%,振幅2.51%,量比0.64。安图生物今日主力资金净流出218万元,连续3日净流出,上一交易日主力净流出21万元,今日环比增加938.10%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为63.16%,平均跌幅为1.45%。该股近5个交易日下跌2.33%,主力资金累计净流入952万元,其中3个交易日为股价上涨时净流出;近20日主力资金累计净流出5474万元,其中净流出天数为16日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126153308a2566d39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126153308a2566d39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0046","603658","BK0239"],"gpt_icon":0},{"id":"2486109861","title":"医药早参|安图生物5项产品获得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2486109861","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486109861?lang=zh_cn&edition=full","pubTime":"2024-11-26 08:02","pubTimestamp":1732579345,"startTime":"0","endTime":"0","summary":"NO.3 力生制药子公司面临1845万元诉讼判决风险11月25日,力生制药公告称,全资子公司天津市中央药业有限公司近日收到天津市第二中级人民法院的民事判决书,涉及与北京凯安瑞医药经营有限公司的销售代理合同纠纷。法院判决天津市中央药业有限公司需支付北京凯安瑞医药经营有限公司推广服务费1110.7万元、奖励费122.4万元、保证金50万元、预付保证金61.9万元及预期利益损失500万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126080426a255896f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126080426a255896f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159938","BK0239","159883","BK0046","603658"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2016-09-01","address":"河南省郑州市管城回族区经济技术开发区经北一路87号","stockEarnings":[{"period":"1week","weight":-0.0042},{"period":"1month","weight":-0.0436},{"period":"3month","weight":0.1631},{"period":"6month","weight":-0.0448},{"period":"1year","weight":-0.1701},{"period":"ytd","weight":-0.1943}],"companyName":"郑州安图生物工程股份有限公司","boardCode":"AI0027","perCapita":"17803股","boardName":"医药制造业","registeredCapital":"58101万元","compareEarnings":[{"period":"1week","weight":-0.007},{"period":"1month","weight":0},{"period":"3month","weight":0.2307},{"period":"6month","weight":0.1234},{"period":"1year","weight":0.154},{"period":"ytd","weight":0.1321}],"survey":" 郑州安图生物工程股份有限公司专业从事体外诊断试剂及仪器的研发、制造、整合及服务,产品涵盖免疫、微生物、生化等检测领域,同时也在分子检测等领域积极布局,能够为医学实验室提供全面的产品解决方案和整体服务。公司产品按照检测方法或应用领域分类,主要分为以下几类:免疫类诊断试剂、微生物检测试剂、生化检测试剂、分子检测试剂、免疫类、微生物类、分子类、临床检验及其他辅助设备。公司产品覆盖了从传染病到非传染病的诸多方向,是我国业内提供免疫检测产品较多的企业之一,也是国内能够提供全面免疫检测解决方案的企业之一。","serverTime":1734732071419,"listedPrice":14.58,"stockholders":"32634人(较上一季度增加6.11%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"安图生物(603658)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供安图生物(603658)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"安图生物,603658,安图生物股票,安图生物股票老虎,安图生物股票老虎国际,安图生物行情,安图生物股票行情,安图生物股价,安图生物股市,安图生物股票价格,安图生物股票交易,安图生物股票购买,安图生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"安图生物(603658)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供安图生物(603658)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}